HomeCompareSNBIF vs QYLD

SNBIF vs QYLD: Dividend Comparison 2026

SNBIF yields 12.16% · QYLD yields 11.92%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 SNBIF wins by $19.2K in total portfolio value
10 years
SNBIF
SNBIF
● Live price
12.16%
Share price
$16.45
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$44.6K
Annual income
$2,595.30
Full SNBIF calculator →
QYLD
Global X Nasdaq 100 Covered Call ETF
● Live price
11.92%
Share price
$17.15
Annual div
$2.04
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$25.4K
Annual income
$5,659.31
Full QYLD calculator →

Portfolio growth — SNBIF vs QYLD

📍 SNBIF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodSNBIFQYLD
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, SNBIF + QYLD cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
SNBIF pays
QYLD pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

SNBIF
Annual income on $10K today (after 15% tax)
$1,033.43/yr
After 10yr DRIP, annual income (after tax)
$2,206.01/yr
QYLD
Annual income on $10K today (after 15% tax)
$1,013.51/yr
After 10yr DRIP, annual income (after tax)
$4,810.41/yr
At 15% tax rate, QYLD beats the other by $2,604.41/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of SNBIF + QYLD for your $10,000?

SNBIF: 50%QYLD: 50%
100% QYLD50/50100% SNBIF
Portfolio after 10yr
$35.0K
Annual income
$4,127.31/yr
Blended yield
11.80%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on QYLD right now

SNBIF
Analyst Ratings
1
Sell
Consensus: Sell
Altman Z
60.9
Piotroski
2/9
QYLD
No analyst data
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

SNBIF buys
0
QYLD buys
0
No recent congressional trades found for SNBIF or QYLD in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricSNBIFQYLD
Forward yield12.16%11.92%
Annual dividend / share$2.00$2.04
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%0%
Portfolio after 10y$44.6K$25.4K
Annual income after 10y$2,595.30$5,659.31
Total dividends collected$18.9K$27.1K
Payment frequencyquarterlymonthly
SectorStockETF

Year-by-year: SNBIF vs QYLD ($10,000, DRIP)

YearSNBIF PortfolioSNBIF Income/yrQYLD PortfolioQYLD Income/yrGap
1← crossover$11,916$1,215.81$10,352$1,192.36+$1.6KSNBIF
2$14,104$1,353.95$10,830$1,347.57+$3.3KSNBIF
3$16,589$1,497.73$11,460$1,539.07+$5.1KSNBIF
4$19,396$1,646.38$12,275$1,777.84+$7.1KSNBIF
5$22,553$1,799.08$13,323$2,078.95+$9.2KSNBIF
6$26,087$1,955.04$14,667$2,463.34+$11.4KSNBIF
7$30,027$2,113.43$16,396$2,960.57+$13.6KSNBIF
8$34,402$2,273.44$18,631$3,612.97+$15.8KSNBIF
9$39,244$2,434.31$21,548$4,482.15+$17.7KSNBIF
10$44,587$2,595.30$25,398$5,659.31+$19.2KSNBIF

SNBIF vs QYLD: Complete Analysis 2026

SNBIFStock

SanBio Company Limited develops, produces, and sells regenerative cell medicines for the central nervous system. The company develops SB623 that has completed a phase 2 clinical trial to treat traumatic brain injury in the United States and Japan. Its research pipeline products also comprise SB623 for ischemic and hemorrhagic strokes, age-related macular degeneration, retinitis pigments, spinal cord injury, Parkinson's disease, Alzheimer's disease, and others; SB618 for peripheral nerve damage; SB308 for muscular dystrophy disease; MSC1 for cancer; and MSC2 for inflammatory disease and optic neuritis. The company was founded in 2001 and is headquartered in Tokyo, Japan.

Full SNBIF Calculator →

QYLDETF

The Global X Nasdaq 100 Covered Call ETF (QYLD) seeks to provide investment results that correspond generally to the price and yield performance, before fees and expenses, of the Cboe Nasdaq-100 BuyWrite V2 Index.

Full QYLD Calculator →
📬

Get this SNBIF vs QYLD comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

SNBIF vs SCHDSNBIF vs JEPISNBIF vs OSNBIF vs KOSNBIF vs MAINSNBIF vs XYLDSNBIF vs JEPQSNBIF vs RYLD

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.